Cited by 478Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and OutcomesNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

Drug Addiction

Camí, Jordi, Farré, Magí·2003·New England Journal of Medicine

DOI 10.1056/nejmra023160

Open this paper in CoChat — free account

Abstract

The neuropsychiatric mechanisms of drug addiction are complex, fascinating, and clinically important. This article reviews the genetic factors, receptor-mediated processes, and anatomical structures involved in drug addiction.

Integrity signals

Registry

Crossref · 10.1056/nejmra023160

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy")
Ricaurte, G. A., Yuan, J., Hatzidimitriou, G., Cord, B. J., & McCann, U. D. (2002) · Science · doi:10.1126/science.1074501 · Cited by 179
Retracted
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex
Goldstein, R. Z., & Volkow, N. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1642 · Cited by 2,667
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Molecular basis of long-term plasticity underlying addiction
Nestler, E. J. (2001) · Nature reviews. Neuroscience · doi:10.1038/35053570 · Cited by 1,893
Addiction
Robinson, T. E., & Berridge, K. C. (2003) · Annual Review of Psychology · doi:10.1146/annurev.psych.54.101601.145237 · Cited by 1,509
Incentive-sensitization and addiction
Robinson, T. E., & Berridge, K. C. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.9611038.x · Cited by 1,435
Addiction and the brain: The neurobiology of compulsion and its persistence
Hyman, S. E., & Malenka, R. C. (2001) · Nature reviews. Neuroscience · doi:10.1038/35094560 · Cited by 1,337
Molecular and Cellular Basis of Addiction
Nestler, E. J., & Aghajanian, G. K. (1997) · Science · doi:10.1126/science.278.5335.58 · Cited by 1,295

Show all 89 references

Research works printed but not linked: 10

Sarnyai Z, 2001, Pharmacol Rev, 53, 209
Farre M, 1997, J Pharmacol Exp Ther, 283, 164
Abraham HD, McCann UD, Ricaurte GA. Psychedelic drugs. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins, 2002:1545-56.
Kalivas PW. Neurocircuitry of addiction. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins, 2002:1357-66.
Konipsky KL, Hyman SE. Molecular and cellular biology of addiction. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins, 2002:1367-79.
Volkow ND, Fowler JS. Application of imaging technologies in the investigation of drug addiction. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins, 2002:1475-90.
Merlo E, Heidbreder C, Mugnaini M, Teneggi V. Molecular and behavioral aspects of nicotine dependence and reward. In: Maldonado R, ed. Molecular biology of drug addiction. Totowa, N.J.: Humana Press, 2002:315-38.
Taylor DA, 2001, J Pharmacol Exp Ther, 297, 11
Caille S, 1999, J Pharmacol Exp Ther, 290, 881
Duman RS, 2001, J Pharmacol Exp Ther, 299, 401

Sorted by citations

2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Primary Prevention of Ischemic Stroke
Goldstein, L. B., Adams, R. J., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., et al. (2006) · Stroke · doi:10.1161/01.str.0000223048.70103.f1 · Cited by 1,376
Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
Involvement of the endocannabinoid system in drug addiction
Maldonado, R. J., Valverde, O., & Berrendero, F. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.008 · Cited by 601
Opioid dependence and addiction during opioid treatment of chronic pain
Ballantyne, J. C., & LaForge, S. K. (2007) · Pain · doi:10.1016/j.pain.2007.03.028 · Cited by 453
The neurocircuitry of addiction: an overview
Feltenstein, M. W., & See, R. E. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.51 · Cited by 421
What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance?
Fernández-Serrano, M. J., Pérez-García, M., & Verdejo-García, A. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.04.008 · Cited by 387
Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction
Aston‐Jones, G., Smith, R. J., Sartor, G. C., Moorman, D. E., Massi, L., Tahsili‐Fahadan, P., & Richardson, K. A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.106 · Cited by 399
Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction
Oviedo‐Joekes, E., Brissette, S., Marsh, D. C., Lauzon, P., Guh, D. P., Anis, A. H., & Schechter, M. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810635 · Cited by 371
The Effects of Toluene on the Central Nervous System
Filley, C. M., HALLIDAY, W. C., & Kleinschmidt‐DeMasters, B. K. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.1.1 · Cited by 364
Efficacy of Opioids for Chronic Pain: A Review of the Evidence
Ballantyne, J., & Shin, N. S. (2008) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31816b2f26 · Cited by 361
Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: a longitudinal study.
Bouso, J. C., González, D., Fondevila, S., Cutchet, M., Fernández, X., Ribeiro Barbosa, P. C., Alcázar-Córcoles, M. Á., Araújo, W. S., Barbanoj, M. J., Fábregas, J. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042421 · Cited by 313
γ-Hydroxybutyric Acid
Snead, O. C., & Gibson, K. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra044047 · Cited by 311
Deep brain stimulation: from neurology to psychiatry?
Krack, P., Hariz, M. I., Baunez, C., Guridi, J., & Obeso, J. A. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.07.002 · Cited by 323
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
Foll, B. L., & Goldberg, S. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077974 · Cited by 294
Suboptimal Addiction Interventions for Patients Hospitalized with Injection Drug Use-Associated Infective Endocarditis
Rosenthal, E. S., Karchmer, A. W., Theisen-Toupal, J. C., Araujo-Castillo, R. V., & Rowley, C. F. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.09.024 · Cited by 282
Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders
Heidbreder, C., & Newman, A. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05149.x · Cited by 303
Internet Sex Addiction Treated With Naltrexone
Bostwick, J. M., & Bucci, J. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.2.226 · Cited by 265
Ketamine abuse potential and use disorder
Liu, Y., Lin, D., Wu, B., & Zhou, W. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.05.016 · Cited by 256
Definition of Substance and Non-substance Addiction
Zou, Z., Wang, H., d’Oleire Uquillas, F., Wang, X., Ding, J., & Chen, H. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-5562-1_2 · Cited by 252
Sleep, Anesthesiology, and the Neurobiology of Arousal State Control
Lydic, R., & Baghdoyan, H. A. (2005) · Anesthesiology · doi:10.1097/00000542-200512000-00024 · Cited by 253
Assessment of addiction severity among ritual users of ayahuasca.
Fábregas, J. M., González, D., Fondevila, S., Cutchet, M., Fernández, X., Barbosa, P. C. R., Alcázar-Córcoles, M. Á., Barbanoj, M. J., Riba, J., & Bouso, J. C. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.03.024 · Cited by 227
Multiple roles for orexin/hypocretin in addiction
Mahler, S. V., Smith, R. J., Moorman, D. E., Sartor, G. C., & Aston-Jones, G. (2012) · Progress in Brain Research · doi:10.1016/b978-0-444-59489-1.00007-0 · Cited by 215
Cannabis and cognitive dysfunction: Parallels with endophenotypes of schizophrenia?
Solowij, N., & Michie, P. T. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0705 · Cited by 202
Overcoming Barriers to Prevention, Care, and Treatment of Hepatitis C in Illicit Drug Users
Edlin, B. R., Kresina, T. F., Raymond, D., Carden, M. R., Gourevitch, M. N., Rich, J. D., Cheever, L. W., & Cargill, V. A. (2005) · Clinical Infectious Diseases · doi:10.1086/427441 · Cited by 194
Impact of general cognition and executive function deficits on addiction treatment outcomes: Systematic review and discussion of neurocognitive pathways
Domínguez‐Salas, S., Díaz, C., Lozano, O. M., & Verdejo‐García, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.09.030 · Cited by 204
The research domain criteria framework: The case for anterior cingulate cortex
Holroyd, C. B., & Umemoto, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.09.021 · Cited by 187
New treatments for cocaine dependence: a focused review.
Karila, L., Gorelick, D., Weinstein, A., Noble, F., Benyamina, A., Coscas, S., Blecha, L., Lowenstein, W., Martinot, J., Reynaud, M., et al. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008097 · Cited by 172
Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics
Farré, M., de la Torre, R., Mathúna, B. Ó., Roset, P. N., Peiró, A. M., Torrens, M., Ortuño, J., Pujadas, M., & Camı́, J. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1789-7 · Cited by 165
Self-citation
Individual variation in resisting temptation: Implications for addiction
Saunders, B. T., & Robinson, T. E. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.008 · Cited by 177
A Qualitative Analysis of Online Gaming Addicts in Treatment
Beranuy, M., Carbonell, X., & Griffiths, M. D. (2012) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-012-9405-2 · Cited by 184
Clinical correlates of tardive dyskinesia in schizophrenia: Baseline data from the CATIE schizophrenia trial
Miller, D. D., McEvoy, J. P., Thomas, S., Caroff, S. N., Saltz, B. L., Chakos, M., Swartz, M. S., Keefe, R. S. E., Rosenheck, R. A., Stroup, T. S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.034 · Cited by 157
Clinical Pharmacokinetics of Amfetamine and Related Substances
de la Torre, R., Farr, M., Navarro, M., Pacifici, R., Zuccaro, P., & Pichini, S. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443030-00002 · Cited by 154
Self-citation
Human Pharmacology of Mephedrone in Comparison with MDMA
Papaseit, E., Pérez‐Mañá, C., Mateus, J. A., Pujadas, M., Fonseca, F., Torrens, M., Olesti, E., de la Torre, R., & Farré, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.75 · Cited by 149
Self-citation
Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls
Rapeli, P., Kivisaari, R., Autti, T. H., Kähkönen, S., Puuskari, V., Jokela, O., & Kalska, H. (2006) · BMC Psychiatry · doi:10.1186/1471-244x-6-9 · Cited by 144
Update and Overview of Practical Epidemiologic Aspects of HIV/AIDS among Injection Drug Users in the United States
Santibanez, S. S., Garfein, R. S., Swartzendruber, A. L., Purcell, D. W., Paxton, L. A., & Greenberg, A. E. (2006) · Journal of Urban Health · doi:10.1007/s11524-005-9009-2 · Cited by 129
Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism
Xing, S., Li, Q., Xiong, B., Chen, Y., Feng, F., Liu, W., & Sun, H. (2020) · Medicinal Research Reviews · doi:10.1002/med.21745 · Cited by 133
Drugs of Abuse, Dopamine, and HIV-Associated Neurocognitive Disorders/HIV-Associated Dementia
Purohit, V., Rapaka, R. S., & Shurtleff, D. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8195-z · Cited by 117
Gut Microbiota Analysis in Rats with Methamphetamine-Induced Conditioned Place Preference
Ning, T., Gong, X., Xie, L., & Ma, B. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01620 · Cited by 116
Medication Overuse Headache (MOH) is a Biobehavioural Disorder
Saper, J., Hamel, R. L., & Lake, A. (2005) · Cephalalgia · doi:10.1111/j.1468-2982.2005.00879.x · Cited by 114
Overview of the pharmacogenomics of cigarette smoking
Ho, M., & Tyndale, R. F. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500436 · Cited by 117
Full Opioid Agonists and Tramadol: Pharmacological and Clinical Considerations
Edinoff, A. N., Kaplan, L. A., Khan, S. U., Petersen, M., Sauce, E., Causey, C. D., Cornett, E. M., Imani, F., Moghaddam, O. M., Kaye, A. M., et al. (2021) · Anesthesiology and Pain Medicine · doi:10.5812/aapm.119156 · Cited by 111
Neural Substrates of Psychostimulant Withdrawal-Induced Anhedonia
D’Souza, M. S., & Markou, A. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_20 · Cited by 108
The "Ups and Downs" of Signaling Cascades in Addiction
Dorit Ron, A., & Jurd, R. (2005) · Science s STKE · doi:10.1126/stke.3092005re14 · Cited by 107
Psychological medicine
(2009) · Elsevier eBooks · doi:10.1016/b978-0-7020-2993-6.00027-4 · Cited by 106
The Human Nucleus Accumbens: Where Is It? A Stereotactic, Anatomical and Magnetic Resonance Imaging Study
Neto, L. L., Oliveira, E., Correia, F., & Gonçalves-Ferreira, A. (2008) · Neuromodulation Technology at the Neural Interface · doi:10.1111/j.1525-1403.2007.00138.x · Cited by 105
Prediction of relapse to frequent heroin use and the role of methadone prescription: An analysis of the Amsterdam Cohort Study among drug users
Termorshuizen, F., Krol, A., Prins, M., Geskus, R. B., van den Brink, W., & van Ameijden, E. J. C. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.01.013 · Cited by 104
Drug-induced Alterations in the Extracellular Signal-regulated Kinase (ERK) Signalling Pathway: Implications for Reinforcement and Reinstatement
Zhai, H., Li, Y., Wang, X., & Lü, L. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9240-3 · Cited by 91
GHB and synthetic cathinones: clinical effects and potential consequences
Karila, L., & Reynaud, M. (2010) · Drug Testing and Analysis · doi:10.1002/dta.210 · Cited by 89
Application of metabolomics to toxicology of drugs of abuse: A mini review of metabolomics approach to acute and chronic toxicity studies
Zaitsu, K., Hayashi, Y., Kusano, M., Tsuchihashi, H., & Ishii, A. (2015) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2015.10.002 · Cited by 92
Neural Substrates and Circuits of Drug AddictionPreprint
Feltenstein, M. W., See, R. E., & Fuchs, R. A. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039628 · Cited by 92
The influence of executive functions, sensation seeking, and HIV serostatus on the risky sexual practices of substance-dependent individuals
Gonzalez, R., Vassileva, J., Bechara, A., Grbesic, S., Sworowski, L., Novak, R., Nunnally, G., & Martin, E. (2005) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617705050186 · Cited by 88
Metabolic profiling of urine and blood plasma in rat models of drug addiction on the basis of morphine, methamphetamine, and cocaine-induced conditioned place preference
Zaitsu, K., Miyawaki, I., Bando, K., Horie, H., Shima, N., Katagi, M., Tatsuno, M., Bamba, T., Sato, T., Ishii, A., et al. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-7234-1 · Cited by 85
Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes
Davis, L. L., Wisniewski, S. R., Howland, R. H., Trivedi, M. H., Husain, M. M., D, M. F. M., McGrath, P. J., Balasubramani, G. K., Warden, D., & Rush, A. J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.003 · Cited by 87
Drug-seeking motivation level in male rats determines offspring susceptibility or resistance to cocaine-seeking behaviour
Le, Q., Yan, B., Yu, X., Li, Y., Song, H., Zhu, H., Hou, W., Ma, D., Wu, F., Zhou, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms15527 · Cited by 84
Combined Neuroimaging, Neurocognitive and Psychiatric Factors to Predict Alcohol Consumption Following Treatment for Alcohol Dependence
Durazzo, T. C., Gazdzinski, S. P., Yeh, P., & Meyerhoff, D. J. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn078 · Cited by 83
Metabolism and metabolomics of opiates: A long way of forensic implications to unravel
Dinis‐Oliveira, R. J. (2018) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2018.12.005 · Cited by 82
Discovery of endogenous opioid systems: what it has meant for the clinician's understanding of pain and its treatment
Ballantyne, J. C., & Sullivan, M. D. (2017) · Pain · doi:10.1097/j.pain.0000000000001043 · Cited by 79
k Opioids as potential treatments for stimulant dependence
Prisinzano, T. E., Tidgewell, K. J., & Harding, W. W. (2005) · The AAPS Journal · doi:10.1208/aapsj070361 · Cited by 79
Psychostimulant Treatment of Cocaine Dependence
Mariani, J. J., & LEVIN, F. R. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.03.012 · Cited by 79
Current and Potential Pharmacological Treatment Options for Maintenance Therapy in Opioid-Dependent Individuals
Tetrault, J. M., & Fiellin, D. A. (2012) · Drugs · doi:10.2165/11597520-000000000-00000 · Cited by 76
Cue-induced alcohol-seeking behaviour is reduced by disrupting the reconsolidation of alcohol-related memories
von der Goltz, C., Vengeliene, V., Bilbao, A., Perreau‐Lenz, S., Pawlak, C. R., Kiefer, F., & Spanagel, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1544-1 · Cited by 77
Early Therapeutic Alliance as a Predictor of Treatment Outcome for Adolescent Cannabis Users in Outpatient Treatment
Diamond, G. S., Liddle, H. A., Wintersteen, M. B., Dennis, M. L., Godley, S. H., & Tims, F. M. (2006) · American Journal on Addictions · doi:10.1080/10550490601003664 · Cited by 83
Bioethics and the Brain
Glannon, W. (2006) · DigitalGeorgetown (Georgetown University Library) · doi:10.1093/acprof:oso/9780195307788.001.0001 · Cited by 75
The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats
Hao, S., Liu, S., Zheng, X., Zheng, W., Ouyang, H., Mata, M., & Fink, D. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.197 · Cited by 74
Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine
Kamens, H. M., Burkhart‐Kasch, S., McKinnon, C. S., Li, N., Reed, C. L., & Phillips, T. J. (2004) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2004.00101.x · Cited by 72
Effects of extended-access self-administration and deprivation on breakpoints maintained by cocaine in rats
Liu, Y., Roberts, D. C. S., & Morgan, D. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2089-y · Cited by 72
Salvinorin A: A novel and highly selective κ-opioid receptor agonist
Yan, F., & Roth, B. L. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.07.008 · Cited by 70
Opioid tolerance and dependence — do they matter?
Jage, J. (2004) · European Journal of Pain · doi:10.1016/j.ejpain.2004.11.009 · Cited by 70
Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)
Lozano, R. P., Farré, M., Yubero‐Lahoz, S., O’Mathúna, B., Torrens, M., Mustata, C., Pérez‐Mañá, C., Langohr, K., Cuyàs, E., Carbó, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047599 · Cited by 74
Self-citation
Genetic Determinants of Addiction to Opioids and Cocaine
Saxon, A. J., Oreskovich, M. R., & Brkanac, Z. (2005) · Harvard Review of Psychiatry · doi:10.1080/10673220500243364 · Cited by 66
Effect of μ-Opioid Receptor Gene Polymorphisms on Heroin-Induced Subjective Responses in a Chinese Population
Zhang, D., Shao, C., Shao, M., Yan, P., Wang, Y., Liu, Y., Liu, W., Lin, T., Xie, Y., Zhao, Y., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.012 · Cited by 63
Safety, pharmacokinetics, and pharmacodynamics of TV‐1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects
Cohen‐Barak, O., Wildeman, J., van de Wetering, J., Hettinga, J., Schuilenga‐Hut, P. H. L., Gross, A., Clark, S., Bassan, M., Gilgun‐Sherki, Y., Mendzelevski, B., et al. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.450 · Cited by 63
Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis
Langford, A. V., Gnjidic, D., Lin, C. C., Bero, L. A., Penm, J. H.-D., Blyth, F., & Schneider, C. R. (2020) · BMJ Quality & Safety · doi:10.1136/bmjqs-2020-010881 · Cited by 62
Rapid and Persistent Sensitization to the Reinforcing Effects of Cocaine
Morgan, D., Liu, Y., & Roberts, D. C. S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300773 · Cited by 62
Aqueous Extract of Saffron (Crocus sativus) Increases Brain Dopamine and Glutamate Concentrations in Rats
Ettehadi, H., Mojabi, S. N., Ranjbaran, M., Shams, J., Sahraei, H., Hedayati, M., & Asefi, F. (2013) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2013.33031 · Cited by 60
Neuropsychiatric Effects of Prescription Drug Abuse
Caplan, J. P., Epstein, L. A., Quinn, D. K., Stevens, J. R., & Stern, T. A. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9037-7 · Cited by 60
Predictors of retention in community-based methadone maintenance treatment program in Pearl River Delta, China
Yang, F., Lin, P., Li, Y., He, Q., Long, Q., Fu, X., & Luo, Y. (2013) · Harm Reduction Journal · doi:10.1186/1477-7517-10-3 · Cited by 60
Feeling ‘better than well’
Hall, W. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400303 · Cited by 59
Need for Analgesics/drugs of Abuse: A Comparison Between Headache Patients and Addicts by the Leeds Dependence Questionnaire (LDQ)
Ferrari, A., Cicero, A., Bertolini, A., Leone, S., Pasciullo, G., & Sternieri, E. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2005.01020.x · Cited by 57
Potential role of safer injection facilities in reducing HIV and Hepatitis C infections and overdose mortality in the United States
Semaan, S., Fleming, P. J., Worrell, C. M., Stolp, H., Baack, B. N., & Miller, M. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.03.006 · Cited by 55
Buprenorphine for the treatment of opioid dependence
Boothby, L. A., & Doering, P. L. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060403 · Cited by 55
Media campaigns for the prevention of illicit drug use in young people
Ferri, M., Allara, E., Bò, A., Gasparrini, A., & Faggiano, F. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009287.pub2 · Cited by 54
A DRD2 and ANKK1 haplotype is associated with nicotine dependence
Voisey, J., Swagell, C. D., Hughes, I. P., van Daal, A., Noble, E. P., Lawford, B. R., Young, R. M., & Morris, C. P. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.09.024 · Cited by 54
Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: Performance and neuroimaging results
Prosser, J. M., London, E. D., & GALYNKER, I. I. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.022 · Cited by 56
Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases
Li, S. H., Abd‐Elrahman, K. S., & Ferguson, S. S. G. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108275 · Cited by 53
COMT val158met and 5-HTTLPR Genetic Polymorphisms Moderate Executive Control in Cannabis Users
Verdejo-García, A., Fagundo, A. B., Cuenca, A., Rodriguez, J., Cuyás, E., Langohr, K., de Sola Llopis, S., Civit, E., Farré, M., Peña-Casanova, J., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.59 · Cited by 53
Self-citation
Binge self-administration and deprivation produces sensitization to the reinforcing effects of cocaine in rats
Morgan, D., Smith, M. A., & Roberts, D. C. S. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1992-6 · Cited by 51
Effects of a Rhodiola rosea L. extract on the acquisition, expression, extinction, and reinstatement of morphine-induced conditioned place preference in mice
Mattioli, L., Titomanlio, F., & Perfumi, M. C. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2686-0 · Cited by 49
Opioid Dependence: Rationale for and Efficacy of Existing and New Treatments
Fiellin, D. A., Friedland, G. H., & Gourevitch, M. N. (2006) · Clinical Infectious Diseases · doi:10.1086/508180 · Cited by 49
Iatrogenic Opioid Withdrawal in Critically Ill Patients: A Review of Assessment Tools and Management
Chiu, A. W., Contreras, S., Mehta, S., Korman, J., Perreault, M. M., Williamson, D. R., & Burry, L. D. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017724538 · Cited by 48
Quantification of Dopamine in Brain Microdialysates with High-Performance Liquid Chromatography-Tandem Mass Spectrometry
Qi, D., Zhang, Q. Y., Zhou, W., Zhao, J., Zhang, B., Sha, Y., & Pang, Z. (2016) · Analytical Sciences · doi:10.2116/analsci.32.419 · Cited by 47
A functional glutathioneS‐transferase P1 gene polymorphism is associated with methamphetamine‐induced psychosis in Japanese population
Hashimoto, T., Hashimoto, K., Matsuzawa, D., Shimizu, E., Sekine, Y., Inada, T., Ozaki, N., Iwata, N., Harano, M., Komiyama, T., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30164 · Cited by 47
Genetics and Genotypes in Irritable Bowel Syndrome: Implications for Diagnosis and Treatment
Park, M. I., & Camilleri, M. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.02.009 · Cited by 46
Opioids for chronic pain: Taking stock
Ballantyne, J. C. (2006) · Pain · doi:10.1016/j.pain.2006.07.005 · Cited by 46
Is Ricoeur's Notion of Narrative Identity Useful in Understanding Recovery in Drug Addicts?
Taïeb, O., Révah‐Levy, A., Moro, M. R., & Baubet, T. (2008) · Qualitative Health Research · doi:10.1177/1049732308318041 · Cited by 45
Special Section on Relapse Prevention: Relapse of Substance Use Disorder and Its Prevention Among Persons With Co-occurring Disorders
McGovern, M. P., Wrisley, B. R., & Drake, R. E. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.10.1270 · Cited by 44
A molecularly defined D1 medium spiny neuron subtype negatively regulates cocaine addiction
Zhao, Z., Han, X., Chen, R., Liu, Y., Bhattacherjee, A., Chen, W., & Zhang, Y. (2022) · Science Advances · doi:10.1126/sciadv.abn3552 · Cited by 44
The brain on opioids
Ballantyne, J. C. (2018) · Pain · doi:10.1097/j.pain.0000000000001270 · Cited by 44

Authors: Camí, J., & Farré, M.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2003-09-04
Volume: 349
Issue: 10
Pages: 975-986
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra023160
OpenAlex: W4244161634
Semantic Scholar: f25e484d34221266586072b4e216a5a3d393e8f6
Cited by: 477
References: 89
Citations by year: 2026: 3 · 2025: 19 · 2024: 16 · 2023: 13 · 2022: 20 · 2021: 29 · 2020: 19 · 2019: 12 · 2018: 21 · 2017: 20 · 2016: 25 · 2015: 15 · 2014: 24 · 2013: 28 · 2012: 14
FWCI: 2.43
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: drug addiction, genetic factors, neuroanatomy, addiction genetics, neurotransmitter receptors
MeSH terms: Ethanol, Animals, Cannabinoids, Cocaine, Disease Models, Animal, Dopamine, Humans, Narcotics, Nicotine, Recurrence, Reinforcement, Psychology, Substance Withdrawal Syndrome, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Drug Addiction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks